Orchestra BioMed: Funding, Investors & Team (Sep 2026)
Ensemble BioMed, Inc. is a biomedical development organization zeroed in on growing high effect, high worth, proof based restorative answers for operations that address significant ailments. Its primary spotlight is on growing new treatments for cardiovascular sicknesses which are the main source of death around the world, ending the existences of 17.7 million individuals every year, or 31% of all worldwide passings as indicated by the World Health Organization. It was established in 2017 and is settled in New Hope, Pennsylvania.
Orchestra BioMed has raised $75.0M across 2 funding rounds on record, the most recent an undisclosed round of $35.0M announced in May 2026.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Orchestra BioMed Company Profile and Key Stats
Latest funding round on record: May 2026.
Orchestra BioMed Funding Rounds
Orchestra BioMed raised $40.0M in a Debt Financing announced in Jul 2022.
3.8 years later, an undisclosed round of $35.0M was announced in May 2026.
Orchestra BioMed Founders and Leadership Team
No contact details are on record for this team yet.
Orchestra BioMed Funding Compared to Other Biotechnology Startups
Orchestra BioMed's latest round of $35.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Orchestra BioMed in Biotechnology and New Hope
Companies Similar to Orchestra BioMed
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Orchestra BioMed Funding FAQs
What does Orchestra BioMed do?
Ensemble BioMed, Inc. is a biomedical development organization zeroed in on growing high effect, high worth, proof based restorative answers for operations that address significant ailments. Its primary spotlight is on growing new treatments for cardiovascular sicknesses which are the main source of death around the world, ending the existences of 17.7 million individuals every year, or 31% of all worldwide passings as indicated by the World Health Organization. It was established in 2017 and is settled in New Hope, Pennsylvania.
How much funding has Orchestra BioMed raised?
Orchestra BioMed has raised $75.0M across 2 rounds on record. The most recent is an undisclosed round of $35.0M announced in May 2026.
When did Orchestra BioMed last raise funding?
Orchestra BioMed's most recent funding round on record is an undisclosed round of $35.0M, announced in May 2026.
Who is the CEO of Orchestra BioMed?
David Hochman is listed as CEO at Orchestra BioMed.
Where is Orchestra BioMed headquartered?
Orchestra BioMed is based in New Hope, Pennsylvania, United States.
How many employees does Orchestra BioMed have?
Orchestra BioMed is in the 11-50 employee band.
How does Orchestra BioMed's funding compare to other Biotechnology startups?
Orchestra BioMed's latest round of $35.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's Orchestra BioMed Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Orchestra BioMed is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.